Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

ROSEVILLE, Minn., Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. CLXT, a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the H.C Wainwright 24^th Annual Global Investment Conference taking place September 12-14, 2022.

H.C. Wainwright 24^th Annual Global Investment Conference
Date: Tuesday, September 13, 2022
Time: 2:30 p.m. ET
Webcast: https://journey.ct.events/view/89f76b34-90f0-4836-b94b-90b001e47b2a

Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to the event organizers or investors@calyxt.com to schedule.

The presentation will be available for viewing and replay from the Investors section of Calyxt's website at www.calyxt.com.

Calyxt CLXT is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.

PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.

Contacts:

SOURCE Calyxt, Inc.